P02768 (ALBU_HUMAN) Homo sapiens (Human)

Albumin UniProtKBInterProSTRINGInteractive Modelling

609 aa; Sequence (Fasta) ; (Isoform 2; Isoform 3)

Available Structures

156 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
Ternary complex of FcRn ectodomain, FcRn binding optimised human serum albumin and the human growth… Heteromer
P55899; P61769;
27-609
MES;CYS;JG5;
Assess
Crystal structure of a high affinity Human Serum Albumin variant bound to the Neonatal Fc Receptor Heteromer
P55899; P61769;
27-609
11×SO4;
Assess
Crystal structure of Nb.b201 bound to human serum albumin Heteromer
26-608
GOL;PLM;DAO;
Assess
Human FcRn complexed with human serum albumin Heteromer
P55899; P61769;
27-609
Assess
Ternary complex between Neonatal Fc receptor, serum albumin and Fc Heteromer
P01857; P55899; P61769;
27-609
NAG;
Assess
Ternary complex of FcRn ectodomain, FcRn binding optimised human serum albumin and the albumin-bini… Heteromer
P55899; P61769;
28-609
MES;JG5;BME;CYS;
Assess
Crystal structure of plasma-derived human serum albumin Heteromer
28-608
EIC;OCA;PLM;TRP; 19×SO4; 13×PEG;PGE;PG4;1PE;
Assess
Crystal structure of human serum albumin in complex with the MCL-1 neutralizing Alphabody CMPX-383B Heteromer
29-608
Assess
Structure of human serum albumin with S-naproxen and the GA module Heteromer
Q51911;
30-608
DKA;NPS;
Assess
Extending the half-life of a Fab fragment through generation of a humanised anti-Human Serum Albumi… Heteromer
29-607
Assess
Crystal structure of a complex between human serum albumin and the antibody Fab SL335 Heteromer
29-606
Assess
Crystal structure of Alb1 megabody in complex with human serum albumin Heteromer
30-607
Assess
Solution structure of the complex between immunoglobulin IgA1 and human serum albumin Heteromer
P01876;
29-606
Assess
Crystal structure of the GA module complexed with human serum albumin Heteromer
Q51911;
29-596
DKA;CIT;
Assess
Shark IgNAR variable domain Heteromer
28-517
Assess
Shark IgNAR Variable Domain Heteromer
28-516
EDO;ACE;
Assess
Crystal Structure of Human serum albumin complexed with Lidocainehomo-2-mer25-606
LQZ;
Assess
Crystal structure of Human Serum Albumin in complex with FESANmonomer25-609
UZC;DMS;MYR;GOL;OCA;SO4;
Assess
Crystal structure of the HSA Fe complexmonomer25-608
GOL;9IZ;FE;PLM;DMS; 16×CL;
Assess
Human Serum Albumin with Cobalt (II) and Myristic Acid - crystal 1monomer25-608
CO; 10×MYR;
Assess
Human Serum Albumin with Cobalt (II) and Myristic Acid - crystal 3monomer25-608
CO;MYR;
Assess
CRYSTAL STRUCTURE OF HUMAN SERUM ALBUMIN (HSA) IN COMPLEX WITH GN-07.monomer26-608
MYR;OQ5;
Assess
X-RAY STUDY OF HUMAN SERUM ALBUMIN COMPLEXED WITH HEMEmonomer26-608
MYR;HEM;
Assess
X-ray study of human serum albumin complexed with 9 amino camptothecinmonomer26-608
MYR;9AZ;
Assess
Crystal Structure Analysis of Human serum albumin complexed with delta 12-prostaglandin J2monomer26-608
MYR;PJ2;
Assess
Crystal structure of human serum albumin and ruthenium PZA complex adductmonomer26-608
PLM;NO;PZA;RU;CL;
Assess
Structure of Human serum albumin-Au compound complexmonomer26-608
PAM;J2O;
Assess
Human Serum Albumin Complexed With Myristic Acid and the R-(+) enantiomer of warfarinmonomer27-609
MYR;RWF;
Assess
Human Serum Albumin Complexed With Myristic Acid and the S-(-) enantiomer of warfarinmonomer27-609
MYR;SWF;
Assess
Crystal structure of Human Serum Albumin in complex with ketoprofenmonomer27-609
CYS;MYR;9KL;EDO;JGE;
Assess
X-ray study of human serum albumin complexed with etoposidemonomer26-608
MYR;EVP;
Assess
Human Serum Albumin with Cobalt (II) and Myristic Acid - crystal 2monomer26-608
CO;MYR;
Assess
Crystal structure of human serum albumin crystallized by ammonium sulfatemonomer26-608
Assess
Structure of Human Serum Albumin in complex with Aristolochic Acid at 1.9 A resolutionmonomer27-608
MYR;EDO;
Assess
Structure of Human Serum Albumin in complex with Aristolochic Acid II at 1.9 A resolutionmonomer27-608
MYR;EDO;GOR;
Assess
Structure of Human Serum Albumin in complex with Aristolochic Acid I at 1.9 A resolution - Optimizedmonomer27-608
MYR;EDO;GOQ;
Assess
Structure of Human Serum Albumin in complex with Myristic Acidmonomer27-608
MYR;EDO;
Assess
Computational design of stable mammalian serum albumins for bacterial expressionmonomer27-608
MYR;RWF;
Assess
Recombinant human serum albumin from transgenic plantmonomer27-608
MYR;
Assess
Crystal structure of Human Serum Albumin complex with JMS-053monomer27-608
MYR;UAY;PG4;OCA;UNL;EDO;
Assess
Human serum albumin-myristate-amantadine hydrochloride complexmonomer27-608
MYR;
Assess
Crystal structure of human serum albumin in complex with phosphorodithioate derivative of myristoyl…monomer27-608
6A4;PGE;PEG;
Assess
Recombinant human serum albumin with palmitic acid. Synthetic cationic antimicrobial peptides bind …monomer27-608
PLM;
Assess
Human serum albumin complexed with dansyl-L-asparagine and myristic acidmonomer27-608
MYR;9DN;
Assess
HUMAN SERUM ALBUMIN COMPLEXED WITH THYROXINE (3,3',5,5'-TETRAIODO-L-THYRONINE) and myristic acid (t…monomer27-608
MYR;T44;
Assess
HUMAN SERUM ALBUMIN COMPLEXED WITH cis-9-OCTADECENOIC ACID (OLEIC ACID)monomer27-608
OLA;
Assess
Human serum albumin complexed with myristate, azapropazone and indomethacinmonomer27-608
MYR;IMN;AZQ;
Assess
HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTIC ACID and the general anesthetic halothanemonomer27-608
MYR;HLT;
Assess
HUMAN SERUM ALBUMIN COMPLEXED WITH DODECANOIC ACID (LAURIC ACID)monomer27-608
DAO;
Assess
Crystal structure of lysophosphatidylcholine in complex with human serum albuminmonomer27-608
LPC;
Assess
Human serum albumin complexed with tetradecanoic acid (myristic acid)monomer27-608
MYR;
Assess
HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTIC ACIDmonomer27-608
MYR;
Assess
Human serum albumin complexed with myristate and indomethacinmonomer27-608
MYR;IMN;
Assess
HUMAN SERUM ALBUMIN COMPLEXED WITH DECANOIC ACID (CAPRIC ACID)monomer27-608
10×DKA;
Assess
Human serum albumin complexed with myristate and azapropazonemonomer27-608
MYR;AZQ;
Assess
Human serum albumin complexed with myristate and AZTmonomer27-608
MYR;AZZ;
Assess
Structure of human serum albumin in complex with DAUDAmonomer27-608
MYR;11D;
Assess
Human serum albumin complexed with myristate, phenylbutazone and indomethacinmonomer27-608
MYR;IMN;P1Z;
Assess
HUMAN SERUM ALBUMIN COMPLEXED WITH cis-5,8,11,14-EICOSATETRAENOIC ACID (ARACHIDONIC ACID)monomer27-608
ACD;
Assess
Human serum albumin complexed with myristate and oxyphenbutazonemonomer27-608
MYR;OPB;
Assess
Human serum albumin complexed with dansyl-L-arginine and myristic acidmonomer27-608
MYR;9NR;
Assess
Human serum albumin complexed with myristate and iodipamidemonomer27-608
MYR;IDB;
Assess
HUMAN SERUM ALBUMIN MUTANT R218H COMPLEXED WITH THYROXINE (3,3',5,5'-TETRAIODO-L-THYRONINE) and myr…monomer27-608
MYR;T44;
Assess
HUMAN SERUM ALBUMIN COMPLEXED WITH OCTADECANOIC ACID (STEARIC ACID)monomer27-608
STE;
Assess
Human serum albumin complexed with myristate and aspirinmonomer27-608
MYR;SAL;
Assess
Human serum albumin complexed with dansyl-L-glutamate and myristic acidmonomer27-608
MYR;9NE;
Assess
Human serum albumin complexed with myristate, 3'-azido-3'-deoxythymidine (AZT) and salicylic acidmonomer27-608
MYR;AZZ;SAL;
Assess
Human serum albumin (HSA) crystallized in the presence of yttrium (III) chloridemonomer27-608
YT3;
Assess
Crystal Structure of Human serum albumin complexed with Myristic acid and lysophosphatidylethanolam…monomer27-608
MYR;LPX;
Assess
Human serum albumin complexed with myristate and salicylic acidmonomer27-608
SAL;MYR;
Assess
X-ray structure of HSA-Myr-KP1019monomer27-608
RU;MYR;
Assess
Human Serum Albuminmonomer26-606
Assess
HSA-Cu agent complexmonomer27-607
PLM;IC4;
Assess
Human serum albumin-Palmitic acid-Cu compoundmonomer27-607
PLM;E5O;
Assess
Crystal structure of Human serum albumin in complex with perfluorooctanoic acid (PFOA) at 2.10 Angs…monomer27-607
8PF;MPO;PGE;PG4;MYR;MPD;EDO;
Assess
Human serum albumin complexed with palmitic acid and diclofenacmonomer27-607
F15;PLM;DIF;
Assess
Crystal structure of Human Serum Albumin in complex with surfactant GenX (2,3,3,3-tetrafluoro-2-(he…monomer27-607
IGB;MPD;MYR;BR;
Assess
Crystal structure of Human Serum albumin in complex with Gemfibrozilmonomer27-607
MYR;4TX;PGE;PG4;MPD;PO4;
Assess
Crystal structure of Human serum albumin in complex with myristic acid at 2.27 Angstrom Resolutionmonomer27-607
MYR;MPD;FMT;PO4;
Assess
Human serum albumin complexed with myristate and phenylbutazonemonomer27-607
MYR;P1Z;
Assess
Crystal structure of human serum albumin complex with aripiprazole and myristic acidmonomer27-607
MYR;9SC;
Assess
Crystal structure analysis of Human Serum Albumin in complex with chloride anions at cryogenic temp…monomer26-606
CL;
Assess
human Serum Albumin complexed with NBD-C12 fatty acidmonomer27-607
C7K;
Assess
X-ray study of human serum albumin complexed with bicalutamidemonomer26-606
198;
Assess
Crystal structure of human serum albumin and nitrosylruthenium complex adductmonomer27-607
RU;HZQ;CL;NO;GOL;DMS;PLM;
Assess
HUMAN SERUM ALBUMIN COMPLEXED WITH HEXADECANOIC ACID (PALMITIC ACID)monomer27-607
PLM;
Assess
Human serum albumin-palladium(II) agent complexmonomer27-607
PLM;U5U;
Assess
HSA-Palmitic acid-[RuCl5(ind)]2-monomer27-607
PLM;7GE;
Assess
Human serum albumin complexed with myristate and 3,5-diiodosalicylic acidmonomer27-607
MYR;DIU;
Assess
Structure and function of human serum albumin-metal agent complexmonomer27-607
PLM;8ZR;
Assess
X-ray study of human serum albumin complexed with teniposidemonomer26-606
9TP;
Assess
HSA-Pt compound complexmonomer27-607
PLM;ZJZ;
Assess
Human serum albumin with cyclic peptide dalbavancinmonomer26-606
JEF;F8F;M12;MAN;
Assess
Human serum albumin-Palmitic acid-Fe(Hn3piT)Cl2monomer27-607
6WF;PLM;
Assess
HSA-In agent complexmonomer27-607
PLM;7Q8;
Assess
lauric acid functionalized hexamolybdoaluminate bound to human serum albuminmonomer27-607
MYR;M6O;
Assess
HUMAN SERUM ALBUMIN IN A COMPLEX WITH MYRISTIC ACID AND TRI-IODOBENZOIC ACIDmonomer28-608
MYR;B3I;
Assess
Crystal structure of Human Serum Albumin in the presence of 0.5 mM zinc at pH 9.0monomer27-606
ZN;UNL;
Assess
X-RAY STUDY OF RECOMBINANT HUMAN SERUM ALBUMIN. PHASES DETERMINED BY MOLECULAR REPLACEMENT METHOD, …monomer28-607
Assess
Human Serum Albuminmonomer28-606
Assess
Human Serum Albumin_1monomer28-606
Assess
Human Serum Albumin, complexed with Sulfasalazinemonomer29-607
DMS;SO4;SAS;
Assess
Human Serum Albumin_2monomer28-606
Assess
Structure of Human Serum Albuminmonomer28-606
Assess
Human serum albumin (apo form)monomer28-606
PO4;
Assess
Crystal structure of lysophosphatidylcholine in complex with human serum albumin and myristatemonomer27-605
MYR;LPC;
Assess
HUMAN SERUM ALBUMIN COMPLEXED WITH TETRADECANOIC ACID (MYRISTIC ACID) AND HEMINmonomer28-606
MYR;HEM;
Assess
HSA Ligand Freemonomer28-606
Assess
Crystal structure of human serum albumin complexed with the general anesthetic propofolmonomer29-606
PFL;
Assess
High-resolution Crystal Structural Variance Analysis between Recombinant and Wild-type Human Serum …monomer29-606
Assess
High-resolution Crystal Structural Variance Analysis between Recombinant and Wild-type Human Serum …monomer29-606
Assess
Human serum albumin complexed with 3-carboxy-4-methyl-5-propyl-2- furanpropanoic acid (CMPF)monomer29-606
C1F;
Assess
Crystal structure of human serum albumin complexed with the general anesthetic halothanemonomer29-606
HLT;
Assess
Human serum albumin complexed with dansyl-L-phenylalaninemonomer29-606
9NF;
Assess
X-ray study of human serum albumin complexed with camptothecinmonomer29-606
EHF;
Assess
HSA-glucose complexmonomer29-606
GLO;GLC;PO4;
Assess
CRYSTAL STRUCTURE OF HUMAN SERUM ALBUMINmonomer29-606
Assess
CRYSTAL STRUCTURE OF HUMAN SERUM ALBUMINmonomer29-606
Assess
Human serum albumin complexed with dansyl-L-norvalinemonomer29-606
9NV;
Assess
Crystal structure of human serum albuminmonomer29-606
Assess
Human serum albumin in complex with compound 3monomer29-606
IQX;
Assess
Human serum albumin in complex with compound 1monomer29-606
IMX;
Assess
Human serum albumin complexed with azapropazonemonomer29-606
AZQ;
Assess
Human serum albumin complexed with ibuprofenmonomer29-606
IBP;
Assess
HUMAN SERUM ALBUMIN COMPLEXED WITH IOPHENOXIC ACIDmonomer29-606
IO3;
Assess
Human serum albumin in complex with compound 2monomer29-606
IPX;PO4;
Assess
X-ray study of human serum albumin complexed with idarubicinmonomer29-606
DM5;
Assess
Crystal structure of HSA-Myr complex soaked with cisplatin for one weekmonomer31-608
CPT;MYR;
Assess
Human serum albumin complexed with dansyl-L-sarcosinemonomer29-606
9DS;
Assess
Human serum albumin complexed with diflunisalmonomer29-606
1FL;
Assess
Human serum albumin complexed with diazepammonomer29-606
DZP;
Assess
Human serum albumin complexed with warfarinmonomer29-606
RWF;
Assess
Human serum albumin complexed with phenylbutazonemonomer29-606
P1Z;
Assess
Human serum albumin complexed with oxyphenbutazonemonomer29-606
OPB;
Assess
Structural studies of human serum albumin using cryo-EM up to 0.38 nm resolutionmonomer29-606
Assess
Human Serum albumin with bound Sulfatemonomer29-603
SO4;
Assess
Human serum albumin complexed with 4Z,15E-bilirubin-IX-alphamonomer29-603
BLA;
Assess
Human serum albumin complexed with dansyl-L-asparaginemonomer29-603
9DN;
Assess
HSA-fructose complexmonomer29-600
FRU;PO4;FUD;
Assess
HUMAN SERUM ALBUMIN MUTANT R218H COMPLEXED WITH THYROXINE (3,3',5,5'-TETRAIODO-L-THYRONINE)monomer29-600
T44;
Assess
Crystal structure of HSA soaked with cisplatin for one weekmonomer28-599
CPT;PO4;
Assess
Human serum albumin complexed with sodium 4-phenylbutyratemonomer27-597
CLT;PO4;
Assess
Human serum albumin mutant r218p complexed with thyroxine (3,3',5,5'-tetraiodo-l-thyronine)monomer29-599
T44;
Assess
Human serum albumin complexed with octanoate and N-acetyl-L-methioninemonomer27-597
AME;OCA;PO4;
Assess
Human serum albumin complexed with aripiprazolemonomer28-597
9SC;PO4;K;
Assess
Human serum albumin complexed with benzbromaronemonomer28-597
R75;
Assess
Structure of a Mcl-1 Inhibitor Binding to Site 3 of Human Serum Albuminmonomer28-595
6AK;PO4;
Assess
Human Serum Albumin Complex with Perfluorooctane Sulfonate Potassiummonomer29-595
P8S;
Assess
Human serum albumin complexed with fusidic acidmonomer29-594
FUA;
Assess
X-ray structure of human serum albumin complexed with cisplatinmonomer29-594
CPT;
Assess
HUMAN SERUM ALBUMIN COMPLEXED WITH THYROXINE (3,3',5,5'-TETRAIODO-L-THYRONINE)monomer29-593
T44;
Assess
Crystal structure of the HSA complex with mycophenolate and aripiprazolemonomer27-591
9SC;MOA;
Assess
Human serum albumin complex with deschloro-aripiprazolemonomer25-588
AJW;PO4;
Assess
Human serum albumin complexed with indoxyl sulfatemonomer29-585
IOS;
Assess
Solution structure of domain 3 from human serum albumin complexed to an anti-apoptotic ligand direc…monomer409-608
4EB;
Assess
Three dimensional structure of EPI-X4, a human albumin-derived peptide that regulates innate immuni…monomer432-447
Assess

1 SWISS-MODEL model

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
6hsc.2.Amonomer0.8327-608
MYR;GOQ;100.00
Assess

3 SWISS-MODEL models built on isoform sequence

TemplateIsoformOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
Isoform 24emx.2.Amonomer0.8022-414
96.21
Assess
Isoform 36hsc.2.Amonomer0.7527-395
MYR;100.00
Assess
Isoform 36hsc.2.Amonomer0.6722-395
MYR;71.70
Assess